1992
DOI: 10.1159/000421298
|View full text |Cite
|
Sign up to set email alerts
|

Combined In Vitro/In Vivo Test Procedure with Human Tumor Xenografts for New Drug Development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
39
0

Year Published

2001
2001
2016
2016

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 55 publications
(40 citation statements)
references
References 0 publications
1
39
0
Order By: Relevance
“…Cell lines derived from the Oncotest collection were established from human tumor xenografts as described by Roth et al (1999). The origin of the donor xenografts was described by Fiebig et al (1992Fiebig et al ( , 1999. The other cell lines were kindly provided by the National Cancer Institute (Bethesda, MD, USA).…”
Section: Antitumor Activitymentioning
confidence: 99%
“…Cell lines derived from the Oncotest collection were established from human tumor xenografts as described by Roth et al (1999). The origin of the donor xenografts was described by Fiebig et al (1992Fiebig et al ( , 1999. The other cell lines were kindly provided by the National Cancer Institute (Bethesda, MD, USA).…”
Section: Antitumor Activitymentioning
confidence: 99%
“…1 Cell Culture. The human tumor xenograft cell lines LXFL529L (large cell lung carcinoma), GXF251L (gastric carcinoma) and CXF97 (colorectal carcinoma) (13) were cultured in RPMI 1640 medium, all with 10% fetal calf serum (FCS) and 1% penicillin/streptomycin in humidified incubators (37°C, 5% CO2). Cell culture medium and supplements were obtained from Gibco Life Technologies (Karlsruhe, Germany).…”
Section: ) 2-hydroxy-2(2′3′-dihydroxy-5′-methyl-2′-cyclopentenon-5′mentioning
confidence: 99%
“…Twenty-four out of the 36 cell lines were established from patient tumors passaged as subcutaneous xenografts in nude mice. [7][8][9] To get clues as to their mechanisms of action, following analysis in the 36 cell line panel of the monolayer assay, novel compounds can be subjected to Compare Analysis. For this, the compounds' IC 70 activity profiles in the 36 cell line panel are compared to the available corresponding activity profiles determined in the same cell lines for more than 100 reference compounds representing diverse mechanisms of action.…”
mentioning
confidence: 99%